Atlas Trials

Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia

Clinical trial NCT01611116 · COMPLETED

Trial details

NCT number
NCT01611116
Sponsor
Goethe University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloblastic Leukemia
Start date
2012-05-01
Primary completion
2017-04-26
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.